CLARKE JOHN K

Average Profitability
26.77%
Insider Buys Quantity
8
Insider Buys Sum
$6.79M
Insider Sells Quantity
2
Insider Sells Sum
$6.78M

Insider Activity of CLARKE JOHN K

The largest purchase of all time was on 2012-02-01 and amounted to 500000 shares of Verastem, Inc. for $5M.

The largest sale of all time was on 2014-05-21 and amounted to 70000 shares of Alnylam Pharmaceuticals, Inc. for $3.77M.

Biography of CLARKE JOHN K

No biography is available at this moment.

2018-05-31SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0301%
$100.31$3.01M-13.32%
2014-05-21SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
70,000
0.0934%
$53.80$3.77M+73.79%
2013-06-12PurchaseVerastem, Inc.
VSTM
director
46,342
0.2163%
$9.60$444,851+24.24%
2013-06-11PurchaseVerastem, Inc.
VSTM
director
50,000
0.2341%
$9.22$460,955+29.74%
2013-05-13PurchaseVerastem, Inc.
VSTM
director
50,000
0.2413%
$9.73$486,750+26.67%
2013-05-01PurchaseVerastem, Inc.
VSTM
director
20,000
0.0983%
$9.66$193,244+30.01%
2013-04-17PurchaseVerastem, Inc.
VSTM
director
11,262
0.0542%
$9.50$106,978+29.41%
2012-12-18PurchaseVerastem, Inc.
VSTM
director
12,386
0.0553%
$7.87$97,478+20.56%
2012-02-01PurchaseVerastem, Inc.
VSTM
director
500,000
3.0936%
$10.00$5M-10.82%
2004-05-27PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
232,500
$0$0
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.